< Back to scientific publications

Magazine 2.07

Extracorporeal photochemotherapy in steroid refractory graft-versus-host disease: experience of Policlinico Tor Vergata”

Authors: Fiorelli E., Lanti A., Ferraro A.S., Basso L., Del Proposto G., Docimo F., Bonchi C., Guiducci G., Massarelli R., Pattofatto F., Ippolito M., Insalaco D., De Masi A., Messina F., Adorno G.

Date: 2014

Scope of interest: Clinical pathology




You may also be interested in:

Report/Poster of Convention/Congress Act

The therapeutic management of the elderly affected by COVID-19 in the various settings

Authors: Abatecola Angela Marie

Date: 2020

Scope of interest: Long term care


Read details
Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy


Read details
Magazine 7.14

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.

Authors: Lattanzi S, Ascoli M, Canafoglia L, Paola Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST group.

Date: 2022

Scope of interest: Epilepsy


Read details